Estrella Immunopharma Statistics
Total Valuation
ESLA has a market cap or net worth of $38.08 million. The enterprise value is $29.03 million.
| Market Cap | 38.08M |
| Enterprise Value | 29.03M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ESLA has 36.61 million shares outstanding. The number of shares has increased by 510.82% in one year.
| Shares Outstanding | 36.61M |
| Shares Change (YoY) | +510.82% |
| Shares Change (QoQ) | +3,244.04% |
| Owned by Insiders (%) | 77.05% |
| Owned by Institutions (%) | 0.82% |
| Float | 9.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.21 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.69, with zero debt.
| Current Ratio | 23.69 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -77.90% |
| Return on Capital (ROIC) | -92.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.81% in the last 52 weeks. The beta is 0.08, so ESLA's price volatility has been lower than the market average.
| Beta (1Y) | 0.08 |
| 52-Week Price Change | -89.81% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 3.78 |
| Relative Strength Index (RSI) | 45.37 |
| Average Volume (30 Days) | 31,040 |
Short Selling Information
The latest short interest is 4,554, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 4,554 |
| Short Previous Month | 7,888 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.36M |
| Pretax Income | -8.36M |
| Net Income | -8.36M |
| EBITDA | -8.36M |
| EBIT | -8.36M |
| Earnings Per Share (EPS) | -$2.90 |
Balance Sheet
The company has $9.05 million in cash and no debt, giving a net cash position of $9.05 million or $0.25 per share.
| Cash & Cash Equivalents | 9.05M |
| Total Debt | n/a |
| Net Cash | 9.05M |
| Net Cash Per Share | $0.25 |
| Equity / Book Value | 9.05M |
| Book Value Per Share | 0.25 |
| Working Capital | 9.05M |
Cash Flow
| Operating Cash Flow | -12.23M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.23M |
| FCF Per Share | -$0.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ESLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -510.82% |
| Shareholder Yield | -510.82% |
| Earnings Yield | -21.97% |
| FCF Yield | -32.11% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |